Experimental Physiology
	

Celebrating 100 years
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Physiology in Press

First published online on February 8, 2008.
Experimental Physiology (2008)
DOI: 10.1113/expphysiol.2007.040311
© The Physiological Society 2008

A more recent version of this article appeared on May 1, 2008
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
93/5/665    most recent
expphysiol.2007.040311v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Elased, K. M.
Right arrow Articles by Morris, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Elased, K. M.
Right arrow Articles by Morris, M.

Received December 6, 2007
Revised January 4, 2008
Accepted after revision February 7, 2008


Autonomic Neuroscience [200]

Brain Angiotensin Converting Enzymes: Role of ACE2 in Processing Angiotensin II

Khalid M. Elased 1, Tatiana Sousa Cunha 2, Fernanda Klein Marcondes 2, Mariana Morris 1*

1 Wright State University
2 State University of Campinas

* To whom correspondence should be addressed. E-mail: mariana.morris{at}wright.edu.


   Abstract
Angiotensin (Ang) converting enzyme-2 (ACE2) metabolizes Ang II to the vasodilatory peptide, Ang (1-7), while neprilysin (NEP) generates Ang (1-7) from Ang I. Experiments used novel SELDI-TOF mass spectroscopic (MS) assays to study Ang processing. MS was used to measure proteolytic conversion of Ang peptide substrates to their specific peptide products. We compared ACE/ACE2 activity in plasma, brain and kidney from C57BL/6 and NEP -/- mice. Plasma or tissue extracts were incubated with Ang I or Ang II (1296 or 1045 m/z, respectively) and generated peptides were monitored with MS. ACE2 activity was detected in kidney and brain, but not plasma. Brain ACE2 activity was highest in hypothalamus. ACE2 activity was inhibited by the specific ACE2 inhibitor, DX600 (10 µM, 99% inhibition), but not by the ACE inhibitor, captopril (10 µM). Both MS and colorimetric assays showed high ACE activity in plasma and kidney with low levels in brain. To extend these findings, ACE measurements were made in ACE over-expressing mice. ACE 4-copy mice showed higher ACE activity in kidney and plasma with low levels in hypothalamus. In hypothalamus from NEP-/-, generation of Ang (1-7) from Ang I was decreased, suggesting a role for NEP in Ang metabolism. With Ang II as substrate, there was no difference between NEP (-/-) and wild type controls, indicating that other enzymes may contribute to generation of Ang (1-7). Data suggest a predominant role of hypothalamic ACE2 in the processing of Ang II in contrast to ACE which is most active in plasma

Key Words: Angiotensin, Enzyme, Hypothalamus




This article has been cited by other articles:


Home page
Exp PhysiolHome page
M. K. Raizada and J. F. R. Paton
Recent advances in the renin-angiotensin system: angiotensin-converting enzyme 2 and (pro)renin receptor
Exp Physiol, May 1, 2008; 93(5): 517 - 518.
[Full Text] [PDF]


Home page
Exp PhysiolHome page
Z. Lin, Y. Chen, W. Zhang, A. F. Chen, S. Lin, and M. Morris
RNA interference shows interactions between mouse brainstem angiotensin AT1 receptors and angiotensin-converting enzyme 2
Exp Physiol, May 1, 2008; 93(5): 676 - 684.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2008 by the The Physiological Society.